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Abstract
Introduction:  Rhinosinusitis  constitutes  an  important  health  problem,  with  signiﬁcant  interfer-
ence in  personal,  professional,  and  social  functioning.  This  study  presents  the  validation  process
of the  Portuguese  version  of  the  RhinoQOL,  to  be  used  as  a  routine  procedure  in  the  assessment
of patients  with  chronic  rhinosinusitis.
Objective:  To  demonstrate  that  the  Portuguese  version  of  the  RhinoQOL  is  as  valid  as  the  English
version to  measure  symptoms  and  health-related  quality  of  life  in  chronic  rhinosinusitis.
Methods: The  Portuguese  version  of  the  RhinoQOL  was  administered  consecutively  to  58
patients with  chronic  rhinosinusitis  with  and  without  nasal  polyps,  assessed  for  endoscopic
sinus surgery.  A  follow-up  survey  was  completed  three  months  after  surgery.  Statistical  analysis
was performed  to  determine  its  psychometric  properties.
Results:  Face  and  content  validity  were  conﬁrmed  by  similar  internal  consistency  as  the  original
questionnaire  for  each  sub-scale,  and  strong  correlation  between  individual  items  and  total
score. The  questionnaire  was  easy  and  quick  to  administer  (5.5  min).  At  three  months,  there  was
a signiﬁcant  decrease  from  baseline  for  all  sub-scale  scores,  indicating  clinical  improvement,
with an  effect  size  considered  as  large.
Conclusion:  This  study  provides  a  questionnaire  that  is  equivalent  to  the  original  English  version,
with good  responsiveness  to  change,  which  can  be  especially  valuable  to  measure  the  outcome
of surgery.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
Elsevier Editora  Ltda.  All  rights  reserved.
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Versão  portuguesa  do  Questionário  RhinoQOL:  validac¸ão  e  aplicac¸ão  clínica
Resumo
Introduc¸ão:  A  rinossinusite  constitui  um  importante  problema  de  saúde,  com  interferência  sig-
niﬁcante na  vida  pessoal,  e  sócio-proﬁssional  dos  pacientes.  Este  estudo  apresenta  o  processo  de
validac¸ão da  versão  do  RhinoQOL  na  língua  portuguesa  para  ser  usado  em  pacientes  portadores
de rinossinusite  crônica.
Objetivo:  Demonstrar  que  a  versão  do  RhinoQOL  na  língua  portuguesa  é  tão  válida  quanto  a
versão inglesa  na  medic¸ão  dos  sintomas  e  qualidade  de  vida  dos  pacientes  com  rinossinusite
crônica.
Método: A  versão  em  português  do  RhinoQOL  foi  aplicada  consecutivamente  a  58  pacientes
com rinossinusite  crônica,  com  e  sem  pólipos  nasais,  previamente  à  cirurgia  endoscópica  nasal,
tendo sido  reavaliados  aos  3  meses  de  pós-operatório.  Análise  estatística  foi  realizada  para
determinar  as  suas  propriedades  psicométricas.
Resultado:  A  validade  de  conteúdo  foi  conﬁrmada  por  uma  consistência  interna  similar  à  do
questionário  original,  para  cada  sub-escala,  e  por  uma  forte  correlac¸ão  entre  cada  item  e  o
score total.  A  aplicac¸ão  do  questionário  foi  fácil  e  rápida  (5,5  min).  Aos  3  meses,  veriﬁcou-se
uma reduc¸ão  signiﬁcativa  dos  scores  de  todas  as  sub-escalas,  indicando  melhoria  clínica,  com
um tamanho  de  efeito  considerado  grande.
Conclusão:  Este  estudo  fornece  um  questionário  que  é  equivalente  à  versão  original,  com  boa
sensibilidade  à  mudanc¸a,  o  que  pode  ser  especialmente  útil  na  medic¸ão  do  impacto  da  cirurgia.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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Symptom frequency scale itemsa
1. Sinus headaches, facial pain, or facial pressure 
2. Blocked or stuffy nose 
3. Postnasal drip 
4. Thick nasal discharge 
5. Runny nose 
Symptom bothersomeness scale itemsb
1. Sinus headaches, facial pain, or facial pressure 
2. Blocked or stuffy nose 
3. Postnasal drip 
Symptom impact scale itemsc
1. Tired or fatigued 
2. Trouble sleeping 
3. Harder to concentrate 
4. Harder to do the things you normally do 
5. Embarrassed 
6. Frustrated 
7. Irritable 
8. Sad or depressed 
9. Think about 
aPatients were asked, “in the last seven days, how much of the time did you have” the
listed symptom. responses included, “never,” “a few times,” “some of the time,” “most
of the time,” and “always.”
bPatients were asked, “using a scale of 0 to 10, where 0 is not bothered at all and 10 is
bother a lot, how much were you bothered by” the listed symptom. responses ranged
from 0 “not bothered at all” to 10 “bothered a lot.”Introduction
Rhinosinusitis,  acute  or  chronic,  with  or  without  nasal
polyps,  constitutes  an  important  health  problem  with  sig-
niﬁcant  impact  on  quality  of  life,  interfering  in  personal,
professional,  and  social  functioning.1
Disease-speciﬁc  instruments  that  measure  symptoms  and
health-related  quality  of  life  (HRQL)  have  been  developed
to  assess  the  impact  of  rhinosinusitis  in  individual  patients,
and  to  monitor  the  response  to  treatment.  There  are  several
questionnaires  (Table  1)  that  subjectively  access  rhinosinusi-
tis  impact  and  associated  incapacity.
One  of  the  major  problems  precluding  the  administra-
tion  of  these  instruments  in  daily  clinical  practice  is  the
lack  of  available  time.  The  need  for  a  brief  and  easy-to-use
rhinosinusitis-speciﬁc  questionnaire  with  strong  psychomet-
ric  characteristics  resulted  in  the  development  of  the
RhinoQOL  Survey  Instrument8 (Fig.  1),  that  has  been  vali-
dated  in  acute8 and  chronic9 rhinosinusitis  patients  treated
both  medically  and  surgically.
This  assessment  instrument,  which  has  been  already  val-
idated  in  French,10 consists  of  17  items,  divided  in  three
domains  addressing  symptom  frequency  (ﬁve  items),  symp-
tom  bothersomeness  (with  answers  ranging  from  0,  meaning
‘‘not  bothered  at  all,’’  to  10,  meaning  ‘‘bothered  a  lot,’’
for  each  of  its  three  items),  and  symptom  impact  (nine
items).  For  the  symptom  frequency  and  impact  questions,
the  patient  has  ﬁve  possible  responses:  ‘‘never,’’  ‘‘a  few
times,’’  ‘‘some  of  the  time,’’  ‘‘most  of  the  time,’’  and
‘‘always.’’
In  a  recent  systematic  review  of  the  available  HRQL  ques-
tionnaires  for  Rhinosinusitis,  the  RhinoQOL  was  one  of  only
cPatients were asked, “in the last seven days, how much of the time did you” have the
listed problem, “because of your nasal symptoms.” responses included, “never,” “a few
times,” “some of the time,” “most of the time,” and “always.” 
Figure  1  RhinoQOL  --  English  version.
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Table  1  Questionnaires  for  assessment  of  quality  of  life  in  rhinosinusitis.
Instrument  Items  Domains  Authors
RSOM-31  Rhinosinusitis  Outcome  Measurement  31  7  Piccirillo2
SNOT-16  Sinonasal  Outcome  Test  16  1  Anderson  et  al.3
SNOT-20  Sinonasal  Outcome  Test  20  1  Piccirillo  et  al.4
SNOT-22  Sinonasal  Outcome  Test  22  1  Hopkins  et  al.5,6
RSDI  Rhinosinusitis  Disability  Index  30  3  Benninger,  Senior7
RhinoQOL  Rhinosinusitis  Quality  of  Life  Survey  Instrument  17  3  Atlas  et  al.8,9
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dwo  (the  other  being  the  RSOM-31)  that  met  the  authors’
riteria  for  discriminant  validity  and  responsiveness.11
This  article  presents  the  translation  to  Portuguese  and
alidation  procedure  of  the  RhinoQOL  to  allow  its  use  in
ssessment  of  chronic  rhinosinusitis  (CRS)  in  Portuguese-
peaking  patients.
ethods
he  present  study  was  approved  by  the  Ethical  Committee
f  a  level  1  hospital  (decision  12/2012)  and  was  performed
ccording  to  the  principles  of  the  Declaration  of  Helsinki.
daptation  to  Portuguese
he  RhinoQOL  questionnaire  was  obtained  from  the  orig-
nal  article  by  Atlas  et  al.9 (Fig.  1).  A  double  translation
f  the  English  questionnaire  into  Portuguese  was  made  by
wo  bilingual  physicians,  followed  by  a  retrotranslation  into
nglish.  The  ﬁnal  form  of  the  validated  Portuguese  version
i
b
a
(
Responda às seguintes questões marcando uma cruz (x) na resposta mais adequada para
RhinoQOL (Rhinosinusitis quality of life survey) - versão portuguesa
1. Nos últimos 7 dias, durante quanto tempo sentiu dor de cabeça, dor na face ou pressão
2. Nos últimos 7 dias, durante quanto tempo sentiu ter o nariz tapado ou congestionado?
3. Nos últimos 7 dias, durante quanto tempo sentiu escorrência por detrás do nariz?
4. Nos últimos 7 dias, durante quanto tempo teve saída de secreçõ es nasais espessas?
5. Nos últimos 7 dias, durante quanto tempo sentiu o nariz a pingar?
6. Nos últimos 7 dias, durante quanto tempo se sentiu cansado(a) por causa dos seus sint
7. Nos últimos 7 dias, durante quanto tempo sentiu dificuldade em dormir por causa dos se
nasais?
8. Nos últimos 7 dias, durante quanto tempo sentiu mais dificuldade em se concentrar por 
sintomas nasais?
9. Nos últimos 7 dias, durante quanto tempo sentiu mais dificuldade em fazer as coisas qu
faz por causa dos seus sintomas nasais?
10. Nos últimos 7 dias, durante quanto tempo se sentiu embaraçado(a) por causa dos seu
11. Nos últimos 7 dias, durante quanto tempo se sentiu frustrado(a) por causa dos seus sin
12. Nos últimos 7 dias, durante quanto tempo se sentiu irritável por causa dos seus sintom
13. Nos últimos 7 dias, durante quanto tempo se sentiu triste ou deprimido(a) por causa do
nasais?
14. Nos últimos 7 dias, durante quanto tempo pensou acerca dos seus sintomas nasais?
Para responder às próximas perguntas, por favor considere todos os sintomas nasais que 
recentemente.
1A. Usando uma escala de 0 a 10, em que 0 significa “nada incomodado” e 10 significa 
que valor atribuiria ao incómodo causado pelas dores de cabeça, dor na face ou pressã
2A. Usando uma escala de 0 a 10, em que 0 significa “nada incomodado” e 10 significa 
que valor atribuiria ao incómodo causado por ter o nariz tapado ou congestionado?
3A. Usando uma escala de 0 a 10, em que 0 significa “nada incomodado” e 10 significa 
que valor atribuiria ao incómodo causado pela escorrência por detrás do nariz?
Figure  2  RhinoQOL  --  Pf  the  RhinoQOL  (RhinoQOL-pv)  is  attached  to  this  article
Fig.  2).
ample  and  procedures
he  study  was  conducted  in  the  Otolaryngology  Department
n  patients  submitted  to  surgery  from  December  1,  2012
o  July  31,  2013.  The  RhinoQOL-pv  was  administered,  dur-
ng  the  consultation,  consecutively  to  the  ﬁrst  58  patients
ith  CRS  with  nasal  polyps  (CRSwNP)  and  without  nasal
olyps  (CRSsNP)  assessed  pre-operatively  for  endoscopic
inus  surgery  (ESS),  which  was  always  performed  by  the  same
urgical  team,  using  the  principles  of  functional  endoscopic
urgery  ﬁrst  described  by  Messerklinger.12 The  sample  size
n  = 58)  was  determined  based  on  the  sample  size  of  the  orig-
nal  study  by  Atlas  et  al.9 (n  =  50),  in  which  it  was  possible  to
etect  clinically  signiﬁcant  differences.  All  persons  provided
nformed  consent  prior  to  their  inclusion  in  the  study.  Eligi-
ility  criteria  included  age  18  or  older  and  ability  to  speak
nd  read  Portuguese.  Administration  time  was  measured
in  minutes).  Patients  were  asked  about  the  clearness  of
 cada pergunta.
Nunca Sempre
0 1 2 3 4 5 6 7 8 9 10
0 1 2 3 4 5 6 7 8 9 10
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tempo
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tempo
Muito
tempo
 na face?
omas nasais?
us sintomas
causa dos seus
e normalmente
s sintomas nasais?
tomas nasais?
as nasais?
s seus sintomas
tem sentido
“muito incomodado”,
o na face?
“muito incomodado”,
“muito incomodado”,
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Table  2  Distribution  of  patients  according  to  sex  and  type
of CRS.
CRSwNP  CRSsNP  Total
Male  20  10  30
Female 18  10  28
0
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questions  (‘‘Did  you  experience  difﬁculties  in  interpreting
any  of  the  items  of  the  questionnaire?’’)  and  the  duration
of  the  assessment  (‘‘Did  you  ﬁnd  the  questionnaire  too  long
to  complete?’’)  with  a  yes/no  answer  option.  Patients  com-
pleted  a  follow-up  survey  three  months  after  surgery.
Statistical  procedure
Data  collected  in  the  assessment  were  introduced  and
processed  by  the  statistical  software  IBMTM SPSSTM Statistics
v.  21.
Descriptive  statistics  of  demographic  and  clinical  data
of  the  sample  were  calculated  (age,  sex,  presence  of  nasal
polyps,  and  Lund--MacKay  score13 in  pre-operative  computed
tomography  scans).
As  in  the  original  study  of  the  RhinoQOL,9 the  psycho-
metric  evaluation  was  performed  separately  for  symptom
frequency,  bothersomeness,  and  impact  scales.  Scores  for
the  symptom  frequency  and  impact  scales  ranged  from  1
(‘‘never’’)  to  5  (‘‘always’’).  For  the  bothersomeness  scale,
scores  ranged  from  0  to  10,  in  accordance  with  the  questions
possible  answers.
Internal  consistency  reliability  was  assessed  using  Cron-
bach’s  alpha.  For  comparison  of  means  between  two
groups,  Student’s  t-test  was  used.  Correlation  between
Lund--MacKay  score  and  RhinoQOL  sub-scale  scores  was
tested  with  Pearson’s  coefﬁcient  for  quantitative  varia-
bles;  correlation  between  each  individual  item  and  total
RhinoQOL-pv  sub-scale  scores  was  tested  with  Spearman’s
coefﬁcient.
The  change  in  scores  between  baseline  and  three  month
follow-up  was  assessed  using  Student’s  t-test  for  paired  sam-
ples.  Responsiveness  was  also  assessed  by  measuring  the
magnitude  of  the  effect,  which  is  the  mean  value  of  vari-
ation  of  the  scores  divided  by  the  standard  deviation  of  the
initial  values.  By  convention,  an  effect  magnitude  between
0.2  and  0.5  is  considered  a  ‘‘mild’’  improvement;  between
4
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Table  3  Total  score  by  sex  for  each  sub-scale.
Sex  n  Frequency  scale  
Mean  SD  
Male  30  14.71  5.01  
Female 28  12.93  4.24  
Signiﬁcance (˛  =  0.05)  0.149  
Table  4  Total  score  by  type  of  CRS  for  each  sub-scale.
n  Frequency  scale  
Mean  SD  
CRSwNP  38  14.79  5.10  
CRSsNP 20  11.90  3.02  
Signiﬁcance (˛  =  0.05)  0.009  
CRSwNP, chronic rhinosinusitis with nasal polyps; CRSsNP, chronic rhinoCRSwNP, chronic rhinosinusitis with nasal polyps; CRSsNP, chronic
rhinosinusitis without nasal polyps.
.5  and  0.8,  ‘‘moderate’’  improvement;  and  greater  than
.8,  a  ‘‘large’’  improvement  in  quality  of  life.6
esults
he  sample  consisted  of  58  patients,  30  men  and  28  women.
ean  age  was  48.48  ±  11.703  years  (range,  25--69  years).
hirty-eight  patients  suffered  from  CRSwNP.  Cases  are  dis-
ributed  according  to  Table  2.
Five  patients  (8.6%)  answered  ‘‘yes’’  to  the  question
bout  difﬁculty  of  interpretation  of  the  items.  On  average,
he  questionnaire  took  5.53  ±  1.127  min  (range,  4--8  min)
o  complete.  Fifty-six  patients  (96.6%)  reported  that  the
hinoQOL-pv  was  not  too  long  to  complete.
Internal  consistency  (Cronbach’s  ˛)  was  0.77,  0.88,  and
.56  for  the  frequency,  impact,  and  bothersomeness  scores,
espectively.
As  depicted  in  Table  3,  male  sex  was  associated  with
ower  total  score  in  the  Symptom  Impact  Scale  than
emale  sex  (Student’s  t-test  signiﬁcance  =  0.018).  Moreover,
RSwNP  was  associated  with  higher  frequency  scale  scores
han  CRSsNP  (Student’s  t-test  signiﬁcance  =  0.009)  (Table  4).
Mean  Lund--Mackay  global  score  was  13.52  ±  4.94  (range,
--23).  Patients  with  CRSwNP  presented  with  higher
und--Mackay  scores  compared  to  patients  with  CRSsNP
Table  5).  A  modest  positive  correlation  (r  =  0.380)  was
btained  between  the  symptom  frequency  sub-scale  of  the
Impact  scale  Bothersomeness  scale
Mean  SD  Mean  SD
17.60  4.66  13.07  6.31
22.71  9.97  15.46  6.41
0.018  0.157
Impact  scale  Bothersomeness  scale
Mean  SD  Mean  SD
19.37  6.72  14.95  7.15
21.40  10.18  12.85  4.56
0.428  0.180
sinusitis without nasal polyps.
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Table  5  Lund--Mackay  total  score  by  type  of  CRS.
n  Mean  SD  Signiﬁcance  (˛  =  0.05)
CRSwNP  38  15.89  3.965 <0.001
CRSsNP  20  9.00  3.112
CRSwNP, chronic rhinosinusitis with nasal polyps; CRSsNP, chronic
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Table  6  Spearman  coefﬁcient  and  signiﬁcance  (two-tailed)
for correlation  between  individual  items  and  total  score  of
each sub-scale  of  the  RhinoQOL-pv  (˛  =  0.05).
Sub-scale  of  RhinoQOL  Item  Spearman  Signiﬁcance
Frequency
1  0.489  <0.001
2 0.605  <0.001
3 0.907 <0.001
4 0.838 <0.001
5 0.763 <0.001
Impact
1 0.739  <0.001
2 0.689  <0.001
3 0.676  <0.001
4 0.643  <0.001
5 0.390  0.002
6 0.844  <0.001
7 0.834  <0.001
8 0.663  <0.001
9 0.653  <0.001
Bothersomeness
1 0.675  <0.001
2 0.670  <0.001
i
i
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experience  major  difﬁculties.rhinosinusitis without nasal polyps.
hinoQOL-pv  and  the  total  Lund--MacKay  score  (p  =  0.003).
o  association  with  other  sub-scales  was  identiﬁed.
Scores  of  every  individual  item  of  the  RhinoQOL-pv  cor-
elated  signiﬁcantly  with  total  score  of  each  sub-scale,  as
hown  in  Table  6.
Scores  on  each  sub-scale  at  baseline  and  three  month
ollow-up  are  shown  in  Table  7.  There  was  a  signiﬁcant
ecrease  from  baseline  for  all  sub-scale  scores,  indicating
linical  improvement.  At  three  months,  the  effect  size  in  all
atients  was  considered  large  for  all  sub-scales  (Table  8).
iscussion
linical  evaluation  of  CRS,  with  and  without  nasal  polyps,  is
ssentially  focused  on  patient  complaints  of  nasal  blockage
nd  discharge,  facial  pain/pressure,  and  reduction  or  loss
f  smell,  with  objective  evidence  of  disease  demonstrated
y  endoscopy  or  CT.  There  is  a  wide  range  of  additional
ssessment  tools;  most  of  them  are  mainly  used  for  research
urposes.1
Questionnaires  that  integrate  patient  reported  symptoms
nd  their  impact  on  HRQL  are  increasingly  useful,  and  their
se  is  now  becoming  a  routine  procedure  in  the  assessment
f  patients  with  rhinosinusitis.  To  date,  the  only  validated
ortuguese  version  of  such  questionnaires  published  in  inter-
ational  literature  is  the  translated  version  of  the  Sinonasal
utcome  Test  (SNOT-22).14
f
R
Table  7  Responsiveness:  scores  at  baseline  and  at  three-month  p
RhinoQOL  sub-scales  Baseline  
n  Mean  SD  
Frequency  58  13.79  4.67  
Impact 58  20.07  8.05  
Bothersomeness  58  14.22  6.42  
Table  8  Responsiveness:  magnitude  of  effect  --  total  sample  and
RhinoQOL  sub-scales  (Meanbaseline −  Mean3
Total  CRSwNP
Frequency  1.07  1.19  
Impact 0.88  0.95  
Bothersomeness  1.39  1.31  
QOL, quality of life; CRSwNP, chronic rhinosinusitis with nasal polyps; C3 0.829  <0.001
The  RhinoQOL  is  a  new  questionnaire  that  showed  valid-
ty  and  responsiveness  comparable  to  the  RSOM-31  and  SNOT
nstruments,  and  demonstrated  excellent  responsiveness  to
hange  over  time  associated  with  surgery.9 The  RhinoQOL-pv
roved  to  be  an  adequate  translation  of  the  English  ver-
ion  as  shown  by  similar  internal  consistency  as  the  original
uestionnaire  for  each  sub-scale  (Table  9),  and  strong  corre-
ation  between  individual  items  and  total  score.  In  addition,
atients  to  whom  the  RhinoQOL-pv  was  administered  did  notOf  the  variables  tested,  sex  was  associated  with  dif-
erences  in  the  total  score  of  the  impact  sub-scale  of  the
hinoQOL-pv,  with  men  presenting  statistically  signiﬁcant
ostoperative  follow-up  (˛  =  0.05).
Three-month  follow-up  p-Value
n  Mean  SD
58  8.79  2.19  <0.001
58  12.95  4.35  <0.001
58  5.31  3.81  <0.001
 by  type  of  CRS.
month)/SDbaseline Improvement  in  QOL
 CRSsNP
0.99  Large
0.83  Large
1.77  Large
RSsNP, chronic rhinosinusitis without nasal polyps.
The  Portuguese  version  of  the  RhinoQOL  Questionnaire  
Table  9  Internal  consistency  reliability  --  Cronbach’s  ˛.
RhinoQOL
(original)9
RhinoQOL-pv
Cronbach’s  ˛  [Frequency]  0.68  0.77
R
1
1
1
1
1Cronbach’s  ˛  [Impact]  0.89  0.88
Cronbach’s  ˛  [Bothersomeness]  0.57  0.56
lower  scores.  This  ﬁnding  raises  the  question  whether  levels
of  reported  distress  may  reﬂect  higher  levels  of  comorbid
anxiety  disorders  known  to  be  more  prevalent  in  women.15
Also,  patients  with  CRSwNP  showed  signiﬁcant  higher  fre-
quency  sub-scale  scores  compared  to  patients  without  nasal
polyps,  but  without  any  statistically  signiﬁcant  differences
in  bothersomeness  and  impact  sub-scale  scores,  suggest-
ing  that  tolerability  to  disease  is  not  different  in  the  two
conditions.
Although  many  studies  have  demonstrated  lack  of  corre-
lation  between  patient  rated  measures  of  symptom  severity
in  CRS  and  objective  measures,1 a  signiﬁcant  yet  modest
positive  correlation  was  veriﬁed  between  the  symptom  fre-
quency  sub-scale  and  the  radiological  Lund--Mackay  scoring
system.
Score  changes  from  baseline  to  the  three-month  postop-
erative  follow-up  showed  that  the  RhinoQOL-pv  is  a useful
tool  in  the  assessment  of  ESS  results,  with  good  responsive-
ness  to  change.  In  fact,  interpretation  of  raw  data  from  the
RhinoQOL-pv  in  a  single  (static)  moment  of  time  may  prove
to  be  difﬁcult,  as  results  are  not  intuitively  inferred;  how-
ever,  interpretation  of  differences  before  and  after  surgical
treatment  appeared  to  be  much  easier  to  perceive.
Conclusion
The  RhinoQOL-pv  can  be  used  for  Portuguese  speaking
patients  with  CRS  as  an  equivalent  of  the  original  English
version,  because  they  have  similar  face  and  content  validity.
This  study  provides  an  instrument  with  good  responsiveness
to  change,  which  could  be  especially  valuable  to  measure
the  outcome  of  ESS.Conﬂicts of interest
The  authors  declare  no  conﬂicts  of  interest.
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